PMC:7228307 / 1010-1263 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"23","span":{"begin":179,"end":226},"obj":"Species"},{"id":"24","span":{"begin":228,"end":238},"obj":"Species"},{"id":"27","span":{"begin":117,"end":124},"obj":"Disease"},{"id":"28","span":{"begin":126,"end":147},"obj":"Disease"},{"id":"29","span":{"begin":160,"end":170},"obj":"Disease"}],"attributes":[{"id":"A23","pred":"tao:has_database_id","subj":"23","obj":"Tax:2697049"},{"id":"A24","pred":"tao:has_database_id","subj":"24","obj":"Tax:2697049"},{"id":"A27","pred":"tao:has_database_id","subj":"27","obj":"MESH:D009369"},{"id":"A28","pred":"tao:has_database_id","subj":"28","obj":"MESH:D007249"},{"id":"A29","pred":"tao:has_database_id","subj":"29","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":" mAb action such as immune agonism or trigger catastrophic adverse effects. The still unmet therapeutic need in many cancers, inflammatory diseases or emerging infections such as severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) requires incr"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T3","span":{"begin":126,"end":147},"obj":"Disease"},{"id":"T4","span":{"begin":160,"end":170},"obj":"Disease"},{"id":"T5","span":{"begin":179,"end":226},"obj":"Disease"},{"id":"T6","span":{"begin":179,"end":212},"obj":"Disease"},{"id":"T7","span":{"begin":228,"end":232},"obj":"Disease"}],"attributes":[{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A6","pred":"mondo_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":" mAb action such as immune agonism or trigger catastrophic adverse effects. The still unmet therapeutic need in many cancers, inflammatory diseases or emerging infections such as severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) requires incr"}

{"project":"LitCovid-sample-PD-IDO","denotations":[{"id":"T6","span":{"begin":139,"end":147},"obj":"http://purl.obolibrary.org/obo/OGMS_0000031"},{"id":"T7","span":{"begin":160,"end":170},"obj":"http://purl.obolibrary.org/obo/IDO_0000586"}],"text":" mAb action such as immune agonism or trigger catastrophic adverse effects. The still unmet therapeutic need in many cancers, inflammatory diseases or emerging infections such as severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) requires incr"}

{"project":"LitCovid-sample-Pubtator","denotations":[{"id":"23","span":{"begin":179,"end":226},"obj":"Species"},{"id":"24","span":{"begin":228,"end":238},"obj":"Species"},{"id":"27","span":{"begin":117,"end":124},"obj":"Disease"},{"id":"28","span":{"begin":126,"end":147},"obj":"Disease"},{"id":"29","span":{"begin":160,"end":170},"obj":"Disease"}],"attributes":[{"id":"A23","pred":"pubann:denotes","subj":"23","obj":"Tax:2697049"},{"id":"A24","pred":"pubann:denotes","subj":"24","obj":"Tax:2697049"},{"id":"A27","pred":"pubann:denotes","subj":"27","obj":"MESH:D009369"},{"id":"A28","pred":"pubann:denotes","subj":"28","obj":"MESH:D007249"},{"id":"A29","pred":"pubann:denotes","subj":"29","obj":"MESH:D007239"}],"text":" mAb action such as immune agonism or trigger catastrophic adverse effects. The still unmet therapeutic need in many cancers, inflammatory diseases or emerging infections such as severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) requires incr"}

{"project":"LitCovid-sample-PD-NCBITaxon","denotations":[{"id":"T2","span":{"begin":179,"end":226},"obj":"Species"},{"id":"T3","span":{"begin":228,"end":238},"obj":"Species"}],"attributes":[{"id":"A2","pred":"ncbi_taxonomy_id","subj":"T2","obj":"NCBItxid:2697049"},{"id":"A3","pred":"ncbi_taxonomy_id","subj":"T3","obj":"NCBItxid:2697049"}],"namespaces":[{"prefix":"NCBItxid","uri":"http://purl.bioontology.org/ontology/NCBITAXON/"}],"text":" mAb action such as immune agonism or trigger catastrophic adverse effects. The still unmet therapeutic need in many cancers, inflammatory diseases or emerging infections such as severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) requires incr"}

{"project":"LitCovid-sample-PD-MONDO","denotations":[{"id":"T2","span":{"begin":126,"end":147},"obj":"Disease"},{"id":"T3","span":{"begin":160,"end":170},"obj":"Disease"},{"id":"T4","span":{"begin":179,"end":226},"obj":"Disease"},{"id":"T5","span":{"begin":228,"end":238},"obj":"Disease"}],"attributes":[{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0021166"},{"id":"A3","pred":"mondo_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"},{"id":"A4","pred":"mondo_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A5","pred":"mondo_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":" mAb action such as immune agonism or trigger catastrophic adverse effects. The still unmet therapeutic need in many cancers, inflammatory diseases or emerging infections such as severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) requires incr"}